Tradestie Institutional Equity Comparison Engine

ARVN vs SLDB โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

SLDB Overall Edge

SLDB Captures Institutional Edge (3โ€“1 Pillars ยท 4โ€“6 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Solid Biosciences Inc. Common Stock (SLDB) driven by superior Growth & Margin, Momentum & Technical, Options & Structure while ARVN counters with relative strength in Valuation. Fundamentally, ARVN trades at 17.9x Forward P/E with -10.1% operating margin (-98.8% YoY revenue) versus SLDB at N/M Forward P/E and 0.0% operating margin (-100.0% YoY). In options structure, ARVN sits in BREAKDOWN (25th %ile IV; Dealer Gamma Walls on Pro) against SLDB sits in BREAKDOWN (15th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner ARVN
ARVN 17.9x vs SLDB N/M Fwd P/E
Growth & Margin Winner SLDB
Op Margin -10.1% vs 0.0% ยท YoY -98.8% vs -100.0%
Momentum & Technical Winner SLDB
1Y -33.4% vs +52.7% ยท 52W Pos 5% vs 33%
Options & Structure Winner SLDB
BREAKDOWN (25th %ile IV) vs BREAKDOWN (15th %ile IV)
ARVN NASDAQ
Arvinas, Inc
Pharmaceutical Preparations
$6.74
-1.17% 1D
Market Cap $449.9M
1M Return -3.3%
1Y Return -33.4%
Forward P/E 17.9x
Unified AI Score
52.9 / 100 HOLD
Tech 54.0 Fund 59.0 Flow 71.0 Mom 54.0
SLDB NASDAQ
Solid Biosciences Inc. Common Stock
Biological Products, (No Disgnostic Substances)
$6.57
-4.02% 1D
Market Cap $781.3M
1M Return +18.72%
1Y Return +52.67%
Forward P/E N/M
Unified AI Score
36.5 / 100 SELL
Tech 15.0 Fund 36.0 Flow 70.0 Mom 40.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: ARVN -33.4% SLDB +52.67% Spread: +86.07 pp (SLDB Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period ARVN Revenue SLDB Revenue ARVN Op. Margin SLDB Op. Margin Margin Edge
FY2018 $10M N/A -306.3% N/A ARVN
FY2019 $20M N/A -281.4% N/A ARVN
FY2020 $20M N/A -554.1% N/A ARVN
FY2021 $50M $10M -403.4% -530.5% ARVN
FY2022 $130M $10M -200.3% -1315.2% ARVN
FY2023 $80M N/A -511.5% N/A ARVN
FY2024 $260M N/A -95.0% N/A ARVN
FY2025 $260M N/A -45.1% N/A ARVN

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: ARVN (6) vs SLDB (4)
Institutional Metric ARVN SLDB Criterion Row Winner
Market Capitalization Scale $449.9M $781.3M Larger Scale SLDB
Trailing P/E Ratio Valuation 17.9x N/M Lower Multiple ARVN
Forward P/E Ratio Valuation 17.9x N/M Lower Multiple ARVN
Revenue Growth (YoY) Growth -98.8% -100.0% Higher Growth ARVN
Operating Margin (TTM) Profitability -10.1% 0.0% Higher Margin SLDB
Net Profit Margin Profitability -3.5% 0.0% Higher Margin SLDB
Return on Equity (ROE) Capital Efficiency -1.8% -76.9% Higher ROE ARVN
52-Week Range Position Momentum 5% ($6โ€“$15) 33% ($4โ€“$11) Stronger Trend SLDB
Beta / 30D Volatility Risk Regime 1.40ฮฒ ยท 66% Vol 2.14ฮฒ ยท 76% Vol Lower Realized Risk ARVN
Unified Institutional Score Composite Signal 52.9 / 100 (HOLD) 36.5 / 100 (SELL) Higher Composite ARVN

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full ARVN vs SLDB Buy Guide
ARVN BREAKDOWN
62d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 25th %ile
IV Regime Balanced (25thโ€“60th %ile)
Live ARVN Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
SLDB BREAKDOWN
93d in phase ยท OBV ACCUMULATION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 15th %ile
IV Regime Compressed (<25th %ile)
Live SLDB Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither ARVN nor SLDB registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.